2seventy bio Revenue and Competitors

Boston, MA USA

Location

$170M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • 2seventy bio's estimated annual revenue is currently $57.7M per year.(i)
  • 2seventy bio's estimated revenue per employee is $155,000
  • 2seventy bio's total funding is $170M.

Employee Data

  • 2seventy bio has 372 Employees.(i)
  • 2seventy bio grew their employee count by -23% last year.

2seventy bio's People

NameTitleEmail/Phone
1
SVP, Development Operations & Portfolio StrategyReveal Email/Phone
2
SVP, Corporate AffairsReveal Email/Phone
3
SVP, QualityReveal Email/Phone
4
SVP, Preclinical and Translational DevelopmentReveal Email/Phone
5
VP Clinical Development OperationsReveal Email/Phone
6
VP, CMC Strategy & OperationsReveal Email/Phone
7
VP - Head Supply Chain & External ManufacturingReveal Email/Phone
8
SVP FinanceReveal Email/Phone
9
Head Quality Assurance, Systems & ComplianceReveal Email/Phone
10
SVP, General CounselReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is 2seventy bio?

We are an immuno-oncology cell therapy company focused on discovering and developing new therapies that truly disrupt the cancer treatment landscape. Our name, 2seventy bio, is inspired by the maximum speed of translating human thought into action—270 miles per hour, and at 2seventy, we think in the language of time. With a deep understanding of cancer cell metabolism, genomics, and the human body’s immune response to tumor cells, we’re applying this knowledge and expertise to new classes of cellular therapies that are designed to “think” smarter and faster than cancer. It is this mindset that propels us forward because we know that time matters -- every day, every minute, every second -- to people living with cancer

keywords:N/A

$170M

Total Funding

372

Number of Employees

$57.7M

Revenue (est)

-23%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$57.8M373-86%N/A
#2
$153.2M377-3%N/A
#3
$68.9M380N/AN/A
#4
$130.6M38729%N/A
#5
$89.1M396N/AN/A